Home > Insider Trading > Filing (0001557007-13-000001)

Filing Details

Accession Number:: 0001557007-13-000001
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2013-10-04 18:02:23
Reporting Period:: 2013-10-03

Filing Date:: 2013-10-04
Accepted Time:: 2013-10-04 18:02:23
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
737207	Marina Biotech Inc.	MRNA	Pharmaceutical Preparations (2834)	112658569

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1557007	Llp Cashman Pryor	7 Times Square, 40Th Floor New York NY 10036		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.006 Per Share	Disposition	2013-10-03	65,000	$0.25	1,735,000	No	4	S	Direct
Common Stock, Par Value $0.006 Per Share	Disposition	2013-10-04	35,000	$0.24	1,700,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	S	Direct
No	4	S	Direct

Footnotes

Represents the weighted average sales price per share. The shares sold at prices ranging from $0.24 to $0.256 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
Represents the weighted average sales price per share. The shares sold at prices ranging from $0.235 to $0.24 per share. Full information regarding the number of shares sold at each price shall be provided upon request of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
The shares that were sold by the Reporting Person in the transactions reported on this Form 4 were acquired by the Reporting Person pursuant to that certain Compromise and Release Agreement dated as of August 21, 2012 between the Reporting Person and the Issuer (the "Agreement"). At that time, in full satisfaction of amounts owing from the Issuer to the Reporting Person for services performed on or prior to August 7, 2012, the Issuer issued to the Reporting Person 1,800,000 shares of common stock (the "Shares"). The Agreement provided that (i) the Shares shall be forfeited to the Issuer on August 1, 2022 unless any one of the following events or transactions have theretofore occurred: (x) a transaction that results in a "change in control" of the Issuer where the shareholders of the Issuer will receive primarily cash and/or marketable securities; (continued to footnote 4)
(continued from footnote 3) (y) a listing of the common stock on Nasdaq, NYSE Amex or any equivalent exchange in the U.S. or any foreign jurisdiction; or (z) the receipt by the Issuer, in aggregate, in excess of $3 million in any combination of capital raises, asset sales or research, license, partnership or other third-party agreements, and (ii) the Reporting Person may not transfer the Shares while the Shares are subject to forfeiture in accordance with the above. On September 18, 2013, the Reporting Person and the Issuer amended the the Agreement so that 100,000 of the Shares were released from the forfeiture provisions and transfer restrictions set forth in the Agreement.